Crave™
PT-141 / Oxytocin / Kisspeptin-10 Blend
10mg / 50mg / 10mg — 5mL
Crave™ is an advanced compounded peptide blend designed to support intimacy, desire, emotional connection, and sexual wellness. This unique formulation combines PT-141, Oxytocin, and Kisspeptin-10 — ingredients commonly utilized in personalized wellness protocols focused on arousal, responsiveness, mood, and connection.
Formulated in a convenient multi-dose 5mL vial, Crave™ is designed for provider-guided therapy tailored to individual wellness goals.
Key Ingredients
PT-141 (Bremelanotide)
PT-141 is a melanocortin peptide studied for its role in supporting sexual desire and arousal pathways independent of vascular mechanisms.
Oxytocin
Often referred to as the “love hormone,” oxytocin plays a role in emotional bonding, intimacy, social connection, and mood regulation.
Kisspeptin-10
Kisspeptin is a naturally occurring signaling peptide involved in reproductive hormone signaling and has been studied for its influence on desire, attraction, and emotional processing.
Potential Benefits
- Supports sexual desire and intimacy
- May enhance emotional connection and responsiveness
- Supports arousal and mood
- Personalized provider-guided peptide therapy
- Convenient compounded formulation
Who May Benefit
Crave™ may be appropriate for individuals seeking support for:
- Low libido
- Decreased intimacy or responsiveness
- Hormonal-related changes in desire
- Emotional connection and relationship wellness
- Sexual wellness optimization
Suggested Use
Use only as directed by your licensed healthcare provider.
Important Information
This compounded medication is prepared specifically for patient-specific needs following medical evaluation and provider approval.
Disclaimer
These statements have not been evaluated by the Food and Drug Administration. Compounded medications are not FDA-approved and are prescribed based on an individualized medical assessment. Results may vary. Not intended to diagnose, treat, cure, or prevent any disease.



Reviews
There are no reviews yet.